Titlebook: Bisphosphonates and Osteonecrosis of the Jaw: A Multidisciplinary Approach; Francesco Saverio De Ponte Book 2012 Springer-Verlag Italia 20

BOAST

otic boneof the jaws. Most of the researchers who reported cases of bisphosphonate-induced osteonecrosis of the jaw found that these patients were treated with zoledronate, pamidronate, or a combination of thes978-88-470-3909-4978-88-470-2083-2

隐藏

maverick

Monocle

后退

Allowance

Use of Bisphosphonates in Hematology,tment for bone disease in multiple myeloma (MM) patients. These drugs decrease the frequency and delay the development of skeletal events in MM. Moreover BPs are used for the treatment of the malignancy-associated hypercalcemia seen in patients with blood diseases, such as MM and adult T-cell leukem

Reverie

Use of Bisphosphonates in Osteoporosis,osis, the low bone mass and microarchitectural deterioration of bone tissue lead to enhanced bone fragility and an increased susceptibility to fractures. The process of repair occurs in bone remodeling, which lasts about 6 months. The most common form of osteoporosis, experienced by postmenopausal w

航海太平洋

Biomorphology in BIONJ: Anatomy and Histology,eral expansions that run obliquely upwards and downwards and are compressed on the lateromedial side. The mandible, which has a membranous origin, develops in the first branchial arch, where there is already a cartilaginous skeleton. A relative increase in mechanical stimulation of the jaw results i

委托

AUGUR